Latent Autoimmune Diabetes in Adults (LADA)--more Than a Name

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2006 Jul 5

PMID 16819610

Citations 13

Authors

L Groop

T Tuomi

M Rowley

P Zimmet

I R Mackay

Affiliations

Soon will be listed here.

Citing Articles

Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.

Golomb R, Tittel S, Welters A, Karges W, Meyhofer S, Hummel M Diabetes Obes Metab. 2024; 27(2):563-573.

PMID: 39529211 PMC: 11701177. DOI: 10.1111/dom.16048.

Screening type 2 Diabetes mellitus among Indians using inflammatory biomarkers.

Arif M, Nigoskar S, Verma M, Amir A Bioinformation. 2024; 20(5):515-519.

PMID: 39132231 PMC: 11309108. DOI: 10.6026/973206300200515.

Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data.

Voeltz D, Brinks R, Tonnies T, Hoyer A BMJ Open Diabetes Res Care. 2023; 11(2).

PMID: 37024151 PMC: 10083786. DOI: 10.1136/bmjdrc-2022-003156.

Inter-relationship of Pro- and Anti- inflammatory Biomarkers with the development of Type 2 Diabetes Mellitus.

Bashir H, Majid S, Khan M, Bhat M, Hamid R, Ashraf R Heliyon. 2022; 8(11):e11329.

PMID: 36387548 PMC: 9641208. DOI: 10.1016/j.heliyon.2022.e11329.

A COMMENTARY ON CLASSIFICATION OF DIABETES: LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA) OR INTERMEDIARY DIABETES MELLITUS (IDM)?.

Ionescu-Tirgoviste C, Gagniuc P, Guja C Acta Endocrinol (Buchar). 2019; 14(4):520-524.

PMID: 31149306 PMC: 6516414. DOI: 10.4183/aeb.2018.520.

References

Tripathy D, Carlsson A, Lehto M, Isomaa B, Tuomi T, Groop L . Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia. 2001; 43(12):1476-83. DOI: 10.1007/s001250051558. View

Grant S, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J . Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38(3):320-3. DOI: 10.1038/ng1732. View

Davis T, Wright A, Mehta Z, Cull C, Stratton I, Bottazzo G . Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia. 2005; 48(4):695-702. DOI: 10.1007/s00125-005-1690-x. View

Groop L, Eriksson J, Ekstrand A, Saloranta C, Miettinen A . Metabolic characteristics of autoimmune diabetes mellitus in adults. Diabetologia. 1991; 34(1):46-51. DOI: 10.1007/BF00404024. View

Fourlanos S, Dotta F, Greenbaum C, Palmer J, Rolandsson O, Colman P . Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005; 48(11):2206-12. DOI: 10.1007/s00125-005-1960-7. View

Isomaa B, Almgren P, Henricsson M, Taskinen M, Tuomi T, Groop L . Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care. 1999; 22(8):1347-53. DOI: 10.2337/diacare.22.8.1347. View

Groop L, Miettinen A, Groop P, Meri S, Koskimies S, Bottazzo G . Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes. 1988; 37(1):99-103. DOI: 10.2337/diab.37.1.99. View

Palmer J, Hampe C, Chiu H, Goel A, Brooks-Worrell B . Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?. Diabetes. 2005; 54 Suppl 2:S62-7. DOI: 10.2337/diabetes.54.suppl_2.s62. View

Scadding J . Essentialism and nominalism in medicine: logic of diagnosis in disease terminology. Lancet. 1996; 348(9027):594-6. DOI: 10.1016/s0140-6736(96)02049-1. View

10.

Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A . Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999; 48(1):150-7. DOI: 10.2337/diabetes.48.1.150. View

11.

Gale E . Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia. 2005; 48(11):2195-9. DOI: 10.1007/s00125-005-1954-5. View

12.

Agardh C, Cilio C, Lethagen A, Lynch K, Leslie R, Palmer M . Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J Diabetes Complications. 2005; 19(4):238-46. DOI: 10.1016/j.jdiacomp.2004.12.003. View

13.

Borg H, Gottsater A, Fernlund P, Sundkvist G . A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes. 2002; 51(6):1754-62. DOI: 10.2337/diabetes.51.6.1754. View

14.

Groop L, Bottazzo G, Doniach D . Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes. 1986; 35(2):237-41. DOI: 10.2337/diab.35.2.237. View

15.

Tuomi T, Groop L, Zimmet P, Rowley M, Knowles W, Mackay I . Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes. 1993; 42(2):359-62. DOI: 10.2337/diab.42.2.359. View

16.

Altshuler D, Hirschhorn J, Klannemark M, Lindgren C, Vohl M, Nemesh J . The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000; 26(1):76-80. DOI: 10.1038/79216. View

17.

Florez J, Burtt N, de Bakker P, Almgren P, Tuomi T, Holmkvist J . Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes. 2004; 53(5):1360-8. DOI: 10.2337/diabetes.53.5.1360. View